1211P IMpower010: ctDNA status and 5y DFS follow up in patients (pts) with resected NSCLC who received adjuvant chemotherapy (chemo) followed by atezolizumab (atezo) or best supportive care (BSC)

H. Wakelee, Martin Reck, Enriqueta Felip, Nassar Altorki, E. Vallieres, Rüediger Liersch, Satoshi Oizumi, Hiroshi Tanaka, John Hamm, Steve McCune, E. Bennett, B.J. Gitlitz, V. McNally, Silvia Novello, M. Ballinger, W. Zou, B. Nabet, M. Srivastava, C.Z. Zhou